For the Inventor, By the Inventor

Enter assignee name

Valneva

USPTO Granted Patents = 10

% Expired Patents = 20.0

EPO Patents = 9

Trademarks = 1

Forward Citations = 14

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Majid Mehtali (6 out of 32 patents)

Fabienne Guehenneux (4 out of 6 patents)

Hiroyuki Kishi (3 out of 6 patents)

4. Atsushi Muraguchi (3 out of 6 patents)

5. Tsutomu Obata (3 out of 3 patents)

6. Arnaud Leon (2 out of 7 patents)

7. Aishun Jin (2 out of 2 patents)

8. Karine Moreau (2 out of 2 patents)

9. Magali Esnault (2 out of 2 patents)

10. Patrick Champion-Arnaud (2 out of 3 patents)

11. Yoshiyuki Yokoyama (1 out of 3 patents)

12. Bertrand Pain (1 out of 6 patents)

13. Yoshiharu Tokimitsu (1 out of 2 patents)

14. Sachiko Kondo (1 out of 1 patent)

15. Hirofumi Nabesawa (1 out of 1 patent)

10 patents: Sort by Forward Citations

1. 9977017 - Apparatus for screening cells (2018-05-22),

2. 9822345 - Method of making a virus using duck embryonic derived stem cell lines (2017-11-21),

3. 9701945 - Production of viral vaccines in suspension on avian embryonic derived stem cell lines (2017-07-11),

4. 9494575 - Cells screening method (2016-11-15),

5. 9382513 - Method of making an avian cell line (2016-07-05),

6. 9310362 - Microwell array chip and method of manufacturing same (2016-04-12),

7. 9260694 - Generation of duck cell lines (2016-02-16),

8. 9182408 - Method of screening by using conformation sensitive peptides (2015-11-10),

9. 9040296 - Production of viral vaccines in suspension on avian embryonic derived stem cell lines (2015-05-26),

10. 8962311 - Method of obtaining chicken embryonic stem cells (2015-02-24),

Valneva is a biotechnology company based in Lyon, France, specializing in the development and commercialization of innovative vaccines. The company focuses on addressing unmet medical needs in infectious diseases, leveraging its expertise in vaccine technology to create solutions for both endemic and epidemic threats. Valneva's research encompasses various platforms, including inactivated and live-attenuated vaccines, with a commitment to enhancing global health through effective immunization strategies.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

10 Patents

#35 in Lyon

#1,710 in France

#55,986 in the World

Valneva

Forward Citations = 14

20 inventors:

Majid Mehtali (6 out of 32 patents)

Fabienne Guehenneux (4 out of 6 patents)

Hiroyuki Kishi (3 out of 6 patents)

4. Atsushi Muraguchi (3 out of 6 patents)

5. Tsutomu Obata (3 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…